search
Back to results

Investigating Inhibitory Control Networks in Parkinson's Disease

Primary Purpose

Parkinson Disease

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Procedure/Surgery: Response Inhibition and Deep Brain Stimulation in Parkinson's disease
Sponsored by
University of Alabama at Birmingham
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Parkinson Disease

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Eligible for DBS surgery based on multi-disciplinary consensus review
  • Have a diagnosis of Parkinson's disease or Essential Tremor
  • A minimum of 18 years of age
  • Willingness to participate in the paradigms described in the protocol

Exclusion Criteria:

  • Inability to provide full and informed consent
  • Are not surgical candidates due to co-morbid conditions or pregnancy
  • Have not undergone an adequate trial of conservative medical management
  • Have a clinical presentation for which DBS surgery is not indicated
  • Are not able to participate in study-related activities

Sites / Locations

  • University of Alabama at BirminghamRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Treatment

Control

Arm Description

Parkinson's Disease Patients receiving DBS electrodes

Control subjects will be non-Parkinson's Disease patients with essential tremor

Outcomes

Primary Outcome Measures

Accuracy via Simon Task (% correct)
In the Simon task, participants are instructed to respond with a right or left button press (Right = Red, Left = Blue) according to how a word is printed on a screen ("RED" or "BLUE"), regardless of the color in which the word is printed. This is a measurement of accuracy (% correct, ranging from 0-100, with higher scores indicating better performance)
Accuracy via Simon Task (% correct)
In the Simon task, participants are instructed to respond with a right or left button press (Right = Red, Left = Blue) according to how a word is printed on a screen ("RED" or "BLUE"), regardless of the color in which the word is printed. This is a measurement of accuracy (% correct, ranging from 0-100, with higher scores indicating better performance)
Response times via Simon Task (sec)
In the Simon task, participants are instructed to respond with a right or left button press according to the word "RIGHT" or "LEFT" that appears on a screen, regardless of where on the screen it actually appears. This is a measurement response times (continuous measure, from 0-4000 milliseconds) between correct and incorrect responses.
Response times via Simon Task (sec)
In the Simon task, participants are instructed to respond with a right or left button press according to the word "RIGHT" or "LEFT" that appears on a screen, regardless of where on the screen it actually appears. This is a measurement response times (continuous measure, from 0-4000 milliseconds) between correct and incorrect responses.
Simon Effect on Response times (sec)
Participants will perform the Simon task as described, and the Simon effect will be calculated as the difference in response times between congruent and incongruent trials
Simon Effect on Response times (sec)
Participants will perform the Simon task as described, and the Simon effect will be calculated as the difference in response times between congruent and incongruent trials
Simon Effect on Accuracy (% correct)
Participants will perform the Simon task as described, and the Simon effect will be calculated as the difference in accuracy between congruent and incongruent trials
Simon Effect on Accuracy (% correct)
Participants will perform the Simon task as described, and the Simon effect will be calculated as the difference in accuracy between congruent and incongruent trials
United Parkinson's disease Rating Scale part 3: Motor Examination Score 0-108 (Higher score represents worse symptoms)
Participants will undergo motor evaluation using the validated United Parkinson's disease Rating Scale (UPDRS) part 3.
United Parkinson's disease Rating Scale part 3: Motor Examination Score 0-108 (Higher score represents worse symptoms)
Participants will undergo motor evaluation using the validated United Parkinson's disease Rating Scale (UPDRS) part 3
Dementia Rating Scale Score 0-144 points (Higher score represents better symptoms)
Participants will undergo neuropsychological testing as part of routine care, including the Dementia Rating Scale
Prefrontal theta-power (microvolt/Hertz)
Participants will undergo intracranial monitoring during DBS surgery in which a prefrontal strip electrode will be placed, enabling measurement of brain activity.
Subcortical theta-power (microvolt/Hertz)
Participants will undergo intracranial monitoring during DBS surgery in which a DBS electrode will be placed, enabling measurement of brain activity at subcortical targets.
Subcortical gamma-power (microvolt/Hertz)
Participants will undergo intracranial monitoring during DBS surgery in which a DBS electrode will be placed, enabling measurement of brain activity at subcortical targets.
Prefrontal gamma-power (microvolt/Hertz)
Participants will undergo intracranial monitoring during DBS surgery in which a prefrontal strip electrode will be placed, enabling measurement of brain activity.
Cortical-subcortical coherence (no units)
Participants will undergo intracranial monitoring during DBS surgery in which a prefrontal strip electrode and DBS electrode will be placed, enabling measurements of connectivity between these structures.

Secondary Outcome Measures

Full Information

First Posted
January 28, 2021
Last Updated
April 24, 2023
Sponsor
University of Alabama at Birmingham
search

1. Study Identification

Unique Protocol Identification Number
NCT04735458
Brief Title
Investigating Inhibitory Control Networks in Parkinson's Disease
Official Title
Investigating Inhibitory Control Networks in Parkinson's Disease
Study Type
Interventional

2. Study Status

Record Verification Date
April 2023
Overall Recruitment Status
Recruiting
Study Start Date
April 1, 2021 (Actual)
Primary Completion Date
March 31, 2025 (Anticipated)
Study Completion Date
March 31, 2026 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Alabama at Birmingham

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
The purpose of this study is to investigate the brain activity associated with non-motor symptoms of movement disorders, including Parkinson's disease and essential tremor. These movement disorders commonly have significant non-motor features also, including depression, cognitive impairment, decreased attention, and slower processing speeds. The investigators are interested in the brain activity associated with these symptoms, and perform recordings of the surface of the brain, in addition to the typical recordings the investigators perform, during routine deep brain stimulation (DBS) surgery.
Detailed Description
Movement disorders are a prominent cause of disability worldwide. In the United States, it is estimated that more than 4 million people suffer from Parkinson's disease (PD), essential tremor (ET), and dystonia, some of the most prevalent of neurologic disorders. Of these, PD is the most common, and is primarily characterized by tremor, rigidity, and bradykinesia. However, many patients also have prominent non-motor features, including depression and cognitive impairment, with deficiencies in processing speed, memory, attention, and learning. One of the most debilitating cognitive deficiencies is in response inhibition (RI), or the inability to suppress a habitual action. PD patients have significant difficulty with RI, and report its substantial contribution in limiting their quality of life. While some studies show that dopamine can improve this aspect of cognitive function, many patients remain considerably impaired. RI manifests clinically in many different and important ways, with reduced mental flexibility, task-switching, and concentration. RI may also contribute to motor impairment, with gait dysfunction, falls, and freezing of gait. Unfortunately, these features of PD and RI are less well-studied and lack effective treatment options, necessitating that new treatments be investigated. Deep brain stimulation (DBS), while a highly effective treatment for motor manifestations, is essentially ineffective for, and can even worsen cognition, with few studies currently investigating how different parameters may improve NMS. In an effort to begin addressing these debilitating features of PD, the investigators propose to study RI in patients with movement disorders, and to correlate movement and cognition with underlying neural electrophysiology before and during tasks of motion and response inhibition. During routine DBS surgery, the stimulating electrode is implanted with the aid of intraoperative recordings in the awake state. These routine recordings enable neurologists and neurosurgeons to directly observe neuronal firing in the brain, identifying characteristic patterns to delineate anatomic structures. Once in place, the DBS electrode is tested using stimulation parameters known to be clinically efficacious for motor impairment. This allows acute, intraoperative testing for therapeutic benefit and side effects, and give information for how a patient will respond to the therapy once the cranial electrode is connected to the battery and turned on. In addition to this routine recording and stimulation, this setting also provides a unique opportunity to study neural electrophysiology, with minimal increased risk. By measuring brain activity in the outer layers (cortex) as well as from the DBS electrode itself, while patients perform various tasks, it is possible to correlate behavioral function and neural activity. Our center, and several others, already have research paradigms in place to achieve these goals, by placing a subdural strip electrode over cortex prior to placing the DBS lead. These strip electrodes lie along the surface of the brain, and have historically been used for several decades to perform seizure mapping, typically as an array of electrodes placed via a burr hole. Their use has only more recently been implemented for investigation of neural circuits during DBS surgery, however, their safety in this specific setting is now well-established, and their temporary placement is currently being performed in similar studies at this institution. However, though previous studies have placed these strips over prefrontal areas, the vast majority of research in this area is focused on motor circuits, with placement over sensorimotor cortex. In order to study NMS, strips will be placed over prefrontal cortex, with recordings made during various motor and cognitive tasks and during different stimulation patterns.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Parkinson Disease

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
60 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Treatment
Arm Type
Experimental
Arm Description
Parkinson's Disease Patients receiving DBS electrodes
Arm Title
Control
Arm Type
No Intervention
Arm Description
Control subjects will be non-Parkinson's Disease patients with essential tremor
Intervention Type
Other
Intervention Name(s)
Procedure/Surgery: Response Inhibition and Deep Brain Stimulation in Parkinson's disease
Intervention Description
After creation of the burr hole and prior to DBS electrode placement, 1-2 subdural strip electrodes will be placed anteriorly or posteriorly from the cranial opening. These electrodes are routinely placed using this technique for seizure mapping, with arrays of electrodes (up to 6) being placed around the perimeter of the opening.14 Subdural strips vary in length and contact size (e.g., the 6-contact Ad-Tech strip), and are currently placed predominantly for studies of sensorimotor function,13 including at our institution (IRB-140327003). Placement over prefrontal areas is performed at other institutions.11-13 The DBS surgery will then proceed according to routine practice, and following lead placement in the optimal desired location, the research task paradigm will begin.
Primary Outcome Measure Information:
Title
Accuracy via Simon Task (% correct)
Description
In the Simon task, participants are instructed to respond with a right or left button press (Right = Red, Left = Blue) according to how a word is printed on a screen ("RED" or "BLUE"), regardless of the color in which the word is printed. This is a measurement of accuracy (% correct, ranging from 0-100, with higher scores indicating better performance)
Time Frame
Baseline
Title
Accuracy via Simon Task (% correct)
Description
In the Simon task, participants are instructed to respond with a right or left button press (Right = Red, Left = Blue) according to how a word is printed on a screen ("RED" or "BLUE"), regardless of the color in which the word is printed. This is a measurement of accuracy (% correct, ranging from 0-100, with higher scores indicating better performance)
Time Frame
0-3 month
Title
Response times via Simon Task (sec)
Description
In the Simon task, participants are instructed to respond with a right or left button press according to the word "RIGHT" or "LEFT" that appears on a screen, regardless of where on the screen it actually appears. This is a measurement response times (continuous measure, from 0-4000 milliseconds) between correct and incorrect responses.
Time Frame
Baseline
Title
Response times via Simon Task (sec)
Description
In the Simon task, participants are instructed to respond with a right or left button press according to the word "RIGHT" or "LEFT" that appears on a screen, regardless of where on the screen it actually appears. This is a measurement response times (continuous measure, from 0-4000 milliseconds) between correct and incorrect responses.
Time Frame
0-3 months
Title
Simon Effect on Response times (sec)
Description
Participants will perform the Simon task as described, and the Simon effect will be calculated as the difference in response times between congruent and incongruent trials
Time Frame
Baseline
Title
Simon Effect on Response times (sec)
Description
Participants will perform the Simon task as described, and the Simon effect will be calculated as the difference in response times between congruent and incongruent trials
Time Frame
0-3 months
Title
Simon Effect on Accuracy (% correct)
Description
Participants will perform the Simon task as described, and the Simon effect will be calculated as the difference in accuracy between congruent and incongruent trials
Time Frame
Baseline
Title
Simon Effect on Accuracy (% correct)
Description
Participants will perform the Simon task as described, and the Simon effect will be calculated as the difference in accuracy between congruent and incongruent trials
Time Frame
0-3 months
Title
United Parkinson's disease Rating Scale part 3: Motor Examination Score 0-108 (Higher score represents worse symptoms)
Description
Participants will undergo motor evaluation using the validated United Parkinson's disease Rating Scale (UPDRS) part 3.
Time Frame
Baseline
Title
United Parkinson's disease Rating Scale part 3: Motor Examination Score 0-108 (Higher score represents worse symptoms)
Description
Participants will undergo motor evaluation using the validated United Parkinson's disease Rating Scale (UPDRS) part 3
Time Frame
0-6 months
Title
Dementia Rating Scale Score 0-144 points (Higher score represents better symptoms)
Description
Participants will undergo neuropsychological testing as part of routine care, including the Dementia Rating Scale
Time Frame
Baseline
Title
Prefrontal theta-power (microvolt/Hertz)
Description
Participants will undergo intracranial monitoring during DBS surgery in which a prefrontal strip electrode will be placed, enabling measurement of brain activity.
Time Frame
0-3 months
Title
Subcortical theta-power (microvolt/Hertz)
Description
Participants will undergo intracranial monitoring during DBS surgery in which a DBS electrode will be placed, enabling measurement of brain activity at subcortical targets.
Time Frame
0-3 months
Title
Subcortical gamma-power (microvolt/Hertz)
Description
Participants will undergo intracranial monitoring during DBS surgery in which a DBS electrode will be placed, enabling measurement of brain activity at subcortical targets.
Time Frame
0-3 months
Title
Prefrontal gamma-power (microvolt/Hertz)
Description
Participants will undergo intracranial monitoring during DBS surgery in which a prefrontal strip electrode will be placed, enabling measurement of brain activity.
Time Frame
0-3 months
Title
Cortical-subcortical coherence (no units)
Description
Participants will undergo intracranial monitoring during DBS surgery in which a prefrontal strip electrode and DBS electrode will be placed, enabling measurements of connectivity between these structures.
Time Frame
0-3 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Eligible for DBS surgery based on multi-disciplinary consensus review Have a diagnosis of Parkinson's disease or Essential Tremor A minimum of 18 years of age Willingness to participate in the paradigms described in the protocol Exclusion Criteria: Inability to provide full and informed consent Are not surgical candidates due to co-morbid conditions or pregnancy Have not undergone an adequate trial of conservative medical management Have a clinical presentation for which DBS surgery is not indicated Are not able to participate in study-related activities
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Nicole Bentley, MD
Phone
205-975-0011
Email
jbentley@uabmc.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Nicole Bentley, MD
Organizational Affiliation
University of Alabama at Birmingham
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Alabama at Birmingham
City
Birmingham
State/Province
Alabama
ZIP/Postal Code
35233
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Nicole Bentley, MD
Phone
205-975-0011
Email
jbentley@uabmc.edu

12. IPD Sharing Statement

Learn more about this trial

Investigating Inhibitory Control Networks in Parkinson's Disease

We'll reach out to this number within 24 hrs